Last Updated: March 28, 2023    


Research Featured

HIV Vaccines March 2023 

Precision Vaccinations | March 3, 2023

Sunlenca Plus Two Antibodies Shows Promise for Twice-Yearly Treatment

POZ | March 28, 2023

Experimental HIV Vaccine Regimen Safe but Ineffective, NIH Study Finds | January 19, 2023

Revolutionary HIV vaccine that 'trains' the immune system passes its first hurdle

Aidsmap | December 19, 2022

HIV Vaccine Trial Makes Pivotal Leap Toward Making 'Super Antibodies’

WebMD | December 2, 2022

California man appears to be another person cured of HIV after a stem cell transplant 

Aidsmap | August 2, 2022

Lenacapavir for HIV-1 — Potential Promise of a Long-Acting Antiretroviral Drug

NEJM | May 12, 2022

Using Science To Solve Oral Health Inequities

National Institute of Dental and Craniofacial Research | June 14, 2022

Combination anti-HIV antibody infusions suppress virus for prolonged period

NIH | June 1, 2022

Top 5 HIV cure and vaccine stories from CROI 2022

Aidsmap | March 2, 2022



News Updates

Woman Free of HIV for 5 Years After Stem Cell Transplant: Researchers

Insider | March 18, 2023

Global study tracks brain infection in people with HIV

VUMC Reporter - Vanderbilt University Medical Center | March 2, 2023

HIV creates reservoirs much earlier than expected, study shows

News Medical | February 28, 2023

HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study 

Lancet HIV. 2023 Feb 28;S2352-3018(23)00008-5. doi: 10.1016/S2352-3018(23)00008-5

Investigational HIV Vaccine and Therapy Combination Reduces Time on ART 

Contagion Live | February 23, 2023

Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: systematic review, meta-analyses and meta-regressions 

Epidemiol Infect. 2023 Feb 8;151:e33. doi: 10.1017/S0950268823000183.

HIV vaccines suffer setbacks but new approaches could turn the tide 

Pharmaceutical Technology | February 3, 2023

HIV vaccine achieves a 97 percent success rate in SMHS human trials

The GW Hatchet | January 31, 2023

Scientists Document Two Separate Reservoirs of Latent HIV in Patients

UNC Health and UNC School of Medicine | January 30, 2023

Why inventing a vaccine for AIDS is tougher than for COVID

NPR | January 26, 2023

Wertheim UF Scripps Institute scientists find potential cellular target for HIV therapies 

UF Health | January 19, 2023

Cure Researchers Convene, Review, Strategize 

amfAR, The Foundation for AIDS Research | January 18, 2023

New Clinical Trials at Leading HIV Center Paused Over Funding Probe

POZ Magazine | January 12, 2023

Developing mucosal vaccines for respiratory viruses

NIH | January 11, 2023

Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency 

ScienceDaily | January 10, 2023

Study participants and their partners need reassurance when treatment interruption required... 

Aidsmap | January 6, 2023

UH Researchers Helping Black Smokers with HIV

University of Houston | January 3, 2023

Researchers Study CRISPR Gene Editing to Cure HIV

POZ Magazine | December 28, 2022

Tel Aviv University researchers demonstrate success of potential one-time vaccine to treat HIV/AIDS 

ET HealthWorld | December 16, 2022

Progress toward an eventual HIV vaccine

NIH | December 13, 2022

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial 

News Medical | December 8, 2022

Researchers reveal new insights into novel HIV vaccine strategy

ET HealthWorld | December 5, 2022

Researchers provide new insights into the vexing process that makes HIV stealthy 

News Medical | November 14, 2022

Do broadly neutralising antibodies really have a future in treating HIV?

Aidsmap | November 11, 2022

A Step Toward Eliminating Reservoir Cells?

amfAR, The Foundation for AIDS Research | November 9, 2022

Researchers at Duke School of Medicine receive $25.9 million grant for HIV vaccine research

Duke Chronicle | November 7, 2022

IDWeek 2022 — Meeting Report

NEJM Journal Watch | November 4, 2022

Potential Cure for HIV from CRISPR Gene Editing in Phase 1/2 Clinical Trial 

Contagion Live | October 16, 2022

Gut Microbes Could Play Role in HIV Infection | October 4, 2022

Study reveals new strategy to create an effective HIV vaccine

Mint | October 4, 2022

HIV Vaccine Shows Promise After Decades of Research

AARP | October 4, 2022

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Nature | October 1, 2022

  2019 Archives 2020 Archives 2021 Archives 2022 Archives